U.S. Markets open in 1 hr 38 mins
S&P Futures
2,432.25
+4.25 (+0.18%)Dow Futures
21,729.00
+37.00 (+0.17%)
| Previous Close | 61.49 |
| Open | 61.48 |
| Bid | 61.38 x 800 |
| Ask | 62.10 x 200 |
| Day's Range | 61.43 - 62.04 |
| 52 Week Range | 58.29 - 66.80 |
| Volume | 7,197,199 |
| Avg. Volume | 8,244,821 |
| Market Cap | 169.5B |
| Beta | 0.96 |
| PE Ratio (TTM) | 39.50 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.88 (3.06%) |
| Ex-Dividend Date | 2017-09-14 |
| 1y Target Est | N/A |
- Zacks•14 hours ago
Zoetis (ZTS) Poised to Grow on Companion Animal Portfolio
Zoetis, Inc. (ZTS) expects to witness stronger growth from its companion animal portfolio in 2017 driven by its dermatology portfolio, Apoquel and Cytopoint, further penetration of Simparica,
- The Wall Street Journal•yesterday
[$$] Scientists, Out $12 Million, Sue Delaware Over Seizure of Their Stock
Two French scientists are suing Delaware because the state sold stock they owned in Idenix Pharmaceuticals without telling them. The case has implications across the U.S. as many companies are incorporated ...
- Market Realist•4 days ago
Opdivo Could Drive Bristol-Myers Squibb’s Revenue Growth in 2017
In 2Q17, Bristol-Myers Squibb’s (BMY) Opdivo generated revenues of around $1.2 billion, which reflected ~45% growth on a year-over-year basis.
